7-151002162-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000603.5(NOS3):c.1648-38G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0829 in 1,468,152 control chromosomes in the GnomAD database, including 5,781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 977 hom., cov: 31)
Exomes 𝑓: 0.080 ( 4804 hom. )
Consequence
NOS3
NM_000603.5 intron
NM_000603.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 7-151002162-G-T is Benign according to our data. Variant chr7-151002162-G-T is described in ClinVar as [Benign]. Clinvar id is 1227505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.157 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOS3 | NM_000603.5 | c.1648-38G>T | intron_variant | ENST00000297494.8 | NP_000594.2 | |||
NOS3 | NM_001160111.1 | c.1648-38G>T | intron_variant | NP_001153583.1 | ||||
NOS3 | NM_001160110.1 | c.1648-38G>T | intron_variant | NP_001153582.1 | ||||
NOS3 | NM_001160109.2 | c.1648-38G>T | intron_variant | NP_001153581.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOS3 | ENST00000297494.8 | c.1648-38G>T | intron_variant | 1 | NM_000603.5 | ENSP00000297494.3 |
Frequencies
GnomAD3 genomes AF: 0.106 AC: 16059AN: 151930Hom.: 979 Cov.: 31
GnomAD3 genomes
AF:
AC:
16059
AN:
151930
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0927 AC: 16634AN: 179452Hom.: 868 AF XY: 0.0955 AC XY: 9139AN XY: 95722
GnomAD3 exomes
AF:
AC:
16634
AN:
179452
Hom.:
AF XY:
AC XY:
9139
AN XY:
95722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0803 AC: 105632AN: 1316104Hom.: 4804 Cov.: 20 AF XY: 0.0826 AC XY: 54069AN XY: 654494
GnomAD4 exome
AF:
AC:
105632
AN:
1316104
Hom.:
Cov.:
20
AF XY:
AC XY:
54069
AN XY:
654494
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.106 AC: 16058AN: 152048Hom.: 977 Cov.: 31 AF XY: 0.107 AC XY: 7969AN XY: 74328
GnomAD4 genome
AF:
AC:
16058
AN:
152048
Hom.:
Cov.:
31
AF XY:
AC XY:
7969
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
429
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at